Article Text
Statistics from Altmetric.com
Commentary on: OpenUrlCrossRefPubMedWeb of Science
Context
Pharmacotherapies directly targeted towards the pathophysiology of erectile dysfunction (ED) are efficacious. But whether lifestyle modification and other pharmacotherapies that target one of the main underlying risks for ED, cardiovascular (CV) risk factors and disease can improve ED remains unclear.
Methods
An online search of peer-reviewed databases was conducted for randomised controlled clinical trials of lifestyle modification or pharmacotherapy of CV risk factors with a minimum intervention period of 6 weeks. Study selection was undertaken with a hierarchical approach by two of the authors acting independently.
Erectile function was assessed with the 5-item International Index of Erectile …
Footnotes
Competing interests None.